Stratec slips in early trade after sales guidance cut
19/10/2022 07:30
** Shares in Stratec SBSG.DE slide 2% in early Frankfurt
trade after the German biomedical technology company cut its
2022 sales guidance urn:newsml:reuters.com:*:nTUCB9CVJR
** "Given the ongoing highly tense supply chain situation,
STRATEC no longer expects to make up for existing delivery
backlogs by the end of the year to the extent originally
planned," it says
** On a constant-currency basis the company now sees 2022
sales to decrease by around 5.0% to 8.0%
** Previously, it had forecast constant-currency sales at
the previous year's level
** The stock is now sitting at the bottom of the German
small-caps index .SDAXI
(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))